Drug Testing Locations - Ewell, MD

Drug Testing in Ewell, MD

Ewell, Maryland Statistics

Ewell, MD, in Somerset County, reported a 10% increase in drug-related hospitalizations in 2022 compared to 2021.

In 2023, Ewell, MD, saw a 5% decrease in opioid overdose deaths, a promising trend for the Somerset County area.

Somerset County, which includes Ewell, recorded 15 drug-related arrests in the first half of 2023.

Ewell, MD reported a 9% rise in substance abuse treatment admissions in 2022 as compared to 2021.

In 2023, 25% of teenagers in Somerset County, including Ewell, admitted to trying drugs at least once.

Police in Ewell, MD, noted a significant uptick in methamphetamine seizures in 2022, surpassing prior years.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Ewell, MD & Drug Testing Policies

Employers in Ewell, MD, maintain stringent drug testing policies to ensure a safe and productive workplace. These policies are in line with state regulations provided by the Maryland Department of Labor which offers guidance on workplace drug testing standards and employee rights.

Routine testing often includes pre-employment screening and random checks. Companies have implemented educational programs emphasizing the dangers of drug use, promoting health and well-being among staff. Non-compliance with drug-free policies usually results in disciplinary action, reflecting a zero-tolerance approach.

Government Efforts with Drug Problems in Ewell, MD

The government of Ewell, MD, in Somerset County has implemented various measures to address drug problems. Initiatives have focused on preventive education and community outreach to raise awareness about the dangers of drug abuse. These efforts are supported by local law enforcement and health agencies.

Focused investments in drug treatment programs have been made to help those battling addiction. Collaborations with state agencies such as the Maryland Department of Health aim to improve accessibility to mental health resources and rehabilitation centers. Comprehensive strategies continue to adapt, tackling the root causes and fostering long-term recovery.

Local Drug Busts & News in Ewell, MD

In recent months, local law enforcement in Ewell, MD, has conducted several drug busts aimed at disrupting drug trafficking operations in Somerset County. One notable raid at the start of 2023 led to multiple arrests and the seizure of significant quantities of controlled substances.

These operations often involve collaboration with state and federal agencies, such as the Drug Enforcement Administration (DEA). Community members are encouraged to report suspicious activities as part of ongoing efforts to curb the local drug trade.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Ewell, MD. Trusted by employers nationwide for accurate results and exceptional service.

Maryland DOT/Non DOT Physicals

Maryland Vision Tests

Maryland Audiograms

Maryland Respirator Fit Tests

Maryland Lift Tests

Maryland Background Checks

Clinical Testing Services

TB Testing in MD

Diabetes Testing in MD

Infectious Disease Testing in MD

Sickle Cell Anemia Testing in MD

Women/Men's Health Testing in MD

Resources & Citations

Maryland Addiction Consultation Service (MACS)

Mid-Shore o-drug Misuse Prevention Program

Somerset County Health Department

Maryland Recovery

Community Behavioral Health

Maryland Coalition Against Sexual Assault

The Santé Group

American Foundation for Suicide Prevention

Drug Testing Near Ewell, MD

Toddville, MD

Mount Vernon, MD

Hoopersville, MD

Nanticoke Acres, MD

Waterview, MD

Nanticoke, MD

Fairmount, MD

Dames Quarter, MD

Chance, MD

Deal Island, MD

Somerset, MD

Lawsonia, MD

Wenona, MD

Crisfield, MD

Smith Island, MD

Frequently Asked Questions

Customer Reviews